Zilganersen, sold under the brand name Zanvastro, is a medication used for the treatment of Alexander disease. It is a glial fibrillary acidic protein (GFAP)-directed antisense oligonucleotide.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.